Daito Pharmaceutical Co (TSE:4577) Moat Score: 0/10 (As of Jul. 09, 2026)


TSE:4577 Daito Pharmaceutical Co Ltd TSE:4577
78 GF Score
Price 円1,249.00
GF Value 円1,279.44
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Daito Pharmaceutical Co Moat Score?

Daito Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Daito Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Daito Pharmaceutical Co might have No Moat - No discernible moat.

Daito Pharmaceutical Co  (TSE:4577) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Daito Pharmaceutical Co Moat Score Related Terms

TSE:4577
78GF Score
Daito Pharmaceutical Co Ltd TSE:4577
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Daito Pharmaceutical Co (TSE:4577) Overvalued in 2026?

Based on GuruFocus' analysis, Daito Pharmaceutical Co stock appears to be undervalued. The current stock price of 円1,249.00 is trading 2.4% below its estimated GF Value™ of 円1,279.44. GuruFocus considers Daito Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4577:

  • Moat Score: 0
  • GF Value™: 円1,279.44 vs. price of 円1,249.00 (2.4% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the TSE:4577 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Daito Pharmaceutical Co Business Description

Address 326 Yokamachi, Toyama, JPN, 939-8567
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.
78GF Score

Get the complete analysis for TSE:4577

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,249.00
Price
円1,279.44
GF Value